<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02752269</url>
  </required_header>
  <id_info>
    <org_study_id>26-446 ex 13/14</org_study_id>
    <nct_id>NCT02752269</nct_id>
  </id_info>
  <brief_title>Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome</brief_title>
  <official_title>Early Detection of Pulmonary- and Pulmonary Vascular Disease in Patients Suffering From Sjögren Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      According to the literature available pulmonary hypertension is present in 12 to 23% of
      patients suffering from Sjögren Syndrome. However epidemiological data are based on
      non-invasive measurements using echocardiography. Furthermore, no data are available
      regarding exercise hemodynamics in those patients.

      This study investigates pulmonary hemodynamics at rest and during exercise in patients
      suffering from primary and secondary Sjögren Syndrome. Patients under suspicion for pulmonary
      hypertension (PH) will be offered further investigations including right heart
      catheterization.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with primary and secondary Sjögren Syndrome will be investigated using
      echocardiography, exercise echocardiography, pulmonary function testing, laboratory testing,
      electrocardiogram and 6 minute walking test. Those patients under clinical suspicion for
      pulmonary hypertension will be offered further investigations including right heart
      catheterization to rule out or verify the diagnosis of manifest pulmonary hypertension.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>prevalence of pulmonary hypertension in Sjögren syndrome</measure>
    <time_frame>2 hours</time_frame>
    <description>% of patients with mean pulmonary arterial pressure &gt; 25 mmHg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>forced vital capacity</measure>
    <time_frame>2 hours</time_frame>
    <description>% predicted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>systolic pulmonary arterial pressure at 50 Watts</measure>
    <time_frame>2 hours</time_frame>
    <description>mmHg</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Sjögren Syndrome</condition>
  <condition>Pulmonary Hypertension</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with primary or secondary Sjögren Syndrome.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  informed Consent

          -  diagnosis of Sjögren Syndrome

          -  age: 18 - 90 yrs

        Exclusion Criteria:

          -  uncontrolled systemic hypertension (at rest &gt;150 mmHg systolic or 95 mmHg diastolic)

          -  relevant systolic (EF&lt;50%) or diastolic (&gt;Grade 1) left ventricular dysfunction

          -  uncontrolled ventricular arrhythmias

          -  uncontrolled supraventricular bradycardia or tachycardia

          -  myocardial infarction within the last 12 months

          -  pulmonary embolism within the last 6 months

          -  larger surgical interventions within the last 12 months

          -  musculoskeletal or vascular disease, that may affect ergometric investigations

          -  pregnancy (anamnesis)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Horst Olschewski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MUG</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Horst Olschewski, MD</last_name>
    <phone>0043 316 385 12183</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Philipp Douschan, MD</last_name>
    <phone>0043 316 385 30184</phone>
    <email>philipp.douschan@medunigraz.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8010</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Horst Olschewski, MD</last_name>
      <phone>0043 316 385 12183</phone>
    </contact>
    <contact_backup>
      <last_name>Philipp Douschan, MD</last_name>
      <phone>0043 316 385 30184</phone>
      <email>philipp.douschan@medunigraz.at</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2015</study_first_submitted>
  <study_first_submitted_qc>April 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2016</study_first_posted>
  <last_update_submitted>February 14, 2018</last_update_submitted>
  <last_update_submitted_qc>February 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Sjogren's Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

